News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Sarepta Therapeutics, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Policy
Sarepta Rockets After the FDA Delays Ruling on DMD Drug
May 25, 2016
·
4 min read
Bio NC
Sarepta Who? This DMD Drugmaker Might be a Better Buy for Investors
May 20, 2016
·
3 min read
FDA
Betting Intensifies Over Sarepta’s DMD Drug
May 6, 2016
·
1 min read
Deals
As Sarepta And Valeant Exit Hearings, Biotech Steps Into M&A
May 3, 2016
·
1 min read
Policy
Rounding Up the Experts’ Thoughts on What’s Next for Sarepta’s DMD Drug
April 27, 2016
·
3 min read
Policy
FDA Panel’s 7-6 Vote Against Sarepta’s DMD Drug Underlines Battle Between Science and Patient Advocates
April 26, 2016
·
5 min read
Policy
Sarepta’s Stock a Rollercoast Ride Prior to Today’s FDA Hearing
April 25, 2016
·
3 min read
FDA
Sarepta Craters as the FDA Releases Documents Ahead of Monday’s DMD Drug Hearing
April 21, 2016
·
3 min read
FDA
36 DMD Experts Send Letter to the FDA Urging Approval of Sarepta’s Drug
March 22, 2016
·
4 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Genetown
Sarepta Therapeutics Reports Sustained Functional Improvement Two Years After Treatment with SRP-9001, its Investigational Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy
September 28, 2020
·
7 min read
Genetown
Sarepta Therapeutics Investigational Gene Therapy SRP-9003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2E Shows Sustained Functional Improvements 18-months After Administration
September 28, 2020
·
8 min read
Genetown
Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program
September 15, 2020
·
3 min read
Genetown
Long-term functional data from Sarepta Therapeutics’ Most Advanced Gene Therapy Programs to be Presented at Upcoming Annual Congress of the World Muscle Society
September 14, 2020
·
4 min read
Genetown
Sarepta Therapeutics Provides Program Update for SRP-9001, its Investigational Gene Therapy for the Treatment of Duchenne Muscular Dystrophy
September 9, 2020
·
5 min read
Genetown
Sarepta Therapeutics to Present at Upcoming Investor Conferences - Sep 03, 2020
September 3, 2020
·
1 min read
Deals
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Aug 31, 2020
August 31, 2020
·
2 min read
Genetown
Sarepta Therapeutics Announces FDA Acceptance of Casimersen (SRP-4045) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 45
August 25, 2020
·
10 min read
Business
Sarepta Therapeutics and University of Florida Announce Collaboration to Accelerate the Discovery and Development of Therapies for Rare Genetic Diseases
August 11, 2020
·
6 min read
Business
Sarepta Therapeutics Announces Second Quarter 2020 Financial Results and Recent Corporate Developments
August 5, 2020
·
30 min read
